Katherine Stueland

Chief Commercial Officer

Back to Speakers

Katherine leads Invitae’s commercial organization, dedicated to driving the company’s mission to bring genetic information into mainstream medical care. Having worked in cancer for most of her career, Katherine is passionate about making life-saving information available to those who need it. She oversees product, sales, marketing, managed care, international, pharma/biotech collaborations, communications, investor relations, public relations, and advocacy initiatives with an eye toward unique, scalable approaches that reduce barriers and increase access to genetic information for all.
Prior to joining the team at Invitae, Katherine worked with private and publicly traded biotech companies, including serving as vice president of communications and investor relations at Dendreon Corporation, the first company to bring an immuno-oncology product to market. Katherine started her career in her hometown of Chicago, where she worked with a portfolio of biotechnology and pharmaceutical companies, including TAP (Takeda/Abbott) Pharmaceuticals.
Katherine serves on the board of The Rivkin Center for Ovarian Cancer and graduated from Miami University in Ohio.